 | • レポートコード：QYR2104Z3024 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品、ヘルスケア |
| Single User | ￥565,500 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥848,250 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,131,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、IGYポリクローナル抗体のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（一次抗体、二次抗体）、用途別市場規模（学術研究、商業）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・IGYポリクローナル抗体の市場動向 ・企業の競争状況、市場シェア ・IGYポリクローナル抗体の種類別市場規模（一次抗体、二次抗体） ・IGYポリクローナル抗体の用途別市場規模（学術研究、商業） ・IGYポリクローナル抗体の北米市場規模2016-2027（アメリカ、カナダ） ・IGYポリクローナル抗体のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・IGYポリクローナル抗体のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・IGYポリクローナル抗体の中南米市場規模2016-2027（メキシコ、ブラジル） ・IGYポリクローナル抗体の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Merck、IGY Life Sciences、Abcam、Genway Biotech、Good Biotech、Gallus Immunotech、Creative Diagnostics、Agrisera、Innovagen AB、Capra Science、YO Proteins、GeneTex） ・結論 |
Immunoglobulin Y (abbreviated as IgY) is a type of immunoglobulin which is the major antibody in bird, reptile, and lungfish blood. It is also found in high concentrations in chicken egg yolk. As with the other immunoglobulins, IgY is a class of proteins which are formed by the immune system in reaction to certain foreign substances, and specifically recognize them.
IgY antibodies have a different structure from IgG, particularly in the Fc and hinge regions. The affinity maturation process of IgY is also different from IgG. These biological features underlie IgY’s competitive advantages over IgG. Shown in the four panels are several comparisons between IgY and IgG.
IgY is a hen egg polyclonal antibody. Hen eggs contain more than 450 separate antibodies and when consumed, are not rejected by the human immune system.
North America is the largest consumption place, with a consumption market share nearly 37.5% in 2017; Europe is the second largest consumption place with the consumption market share of 30% in 2017.
Market Analysis and Insights: Global IGY Polyclonal Antibodies Market
The global IGY Polyclonal Antibodies market size is projected to reach US$ 14 million by 2026, from US$ 6 million in 2019, at a CAGR of 13.4% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global IGY Polyclonal Antibodies market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global IGY Polyclonal Antibodies market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global IGY Polyclonal Antibodies market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global IGY Polyclonal Antibodies market.
Global IGY Polyclonal Antibodies Scope and Market Size
IGY Polyclonal Antibodies market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global IGY Polyclonal Antibodies market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Primary Antibody
Secondary Antibody
Segment by Application
Academic Research
Commercial
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Merck
IGY Life Sciences
Abcam
Genway Biotech
Good Biotech
Gallus Immunotech
Creative Diagnostics
Agrisera
Innovagen AB
Genway Biotech
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global IGY Polyclonal Antibodies Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Primary Antibody
1.2.3 Secondary Antibody
1.3 Market by Application
1.3.1 Global IGY Polyclonal Antibodies Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Academic Research
1.3.3 Commercial
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global IGY Polyclonal Antibodies Market Perspective (2016-2027)
2.2 IGY Polyclonal Antibodies Growth Trends by Regions
2.2.1 IGY Polyclonal Antibodies Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 IGY Polyclonal Antibodies Historic Market Share by Regions (2016-2021)
2.2.3 IGY Polyclonal Antibodies Forecasted Market Size by Regions (2022-2027)
2.3 IGY Polyclonal Antibodies Industry Dynamic
2.3.1 IGY Polyclonal Antibodies Market Trends
2.3.2 IGY Polyclonal Antibodies Market Drivers
2.3.3 IGY Polyclonal Antibodies Market Challenges
2.3.4 IGY Polyclonal Antibodies Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top IGY Polyclonal Antibodies Players by Revenue
3.1.1 Global Top IGY Polyclonal Antibodies Players by Revenue (2016-2021)
3.1.2 Global IGY Polyclonal Antibodies Revenue Market Share by Players (2016-2021)
3.2 Global IGY Polyclonal Antibodies Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by IGY Polyclonal Antibodies Revenue
3.4 Global IGY Polyclonal Antibodies Market Concentration Ratio
3.4.1 Global IGY Polyclonal Antibodies Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by IGY Polyclonal Antibodies Revenue in 2020
3.5 IGY Polyclonal Antibodies Key Players Head office and Area Served
3.6 Key Players IGY Polyclonal Antibodies Product Solution and Service
3.7 Date of Enter into IGY Polyclonal Antibodies Market
3.8 Mergers & Acquisitions, Expansion Plans
4 IGY Polyclonal Antibodies Breakdown Data by Type
4.1 Global IGY Polyclonal Antibodies Historic Market Size by Type (2016-2021)
4.2 Global IGY Polyclonal Antibodies Forecasted Market Size by Type (2022-2027)
5 IGY Polyclonal Antibodies Breakdown Data by Application
5.1 Global IGY Polyclonal Antibodies Historic Market Size by Application (2016-2021)
5.2 Global IGY Polyclonal Antibodies Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America IGY Polyclonal Antibodies Market Size (2016-2027)
6.2 North America IGY Polyclonal Antibodies Market Size by Type
6.2.1 North America IGY Polyclonal Antibodies Market Size by Type (2016-2021)
6.2.2 North America IGY Polyclonal Antibodies Market Size by Type (2022-2027)
6.2.3 North America IGY Polyclonal Antibodies Market Size by Type (2016-2027)
6.3 North America IGY Polyclonal Antibodies Market Size by Application
6.3.1 North America IGY Polyclonal Antibodies Market Size by Application (2016-2021)
6.3.2 North America IGY Polyclonal Antibodies Market Size by Application (2022-2027)
6.3.3 North America IGY Polyclonal Antibodies Market Size by Application (2016-2027)
6.4 North America IGY Polyclonal Antibodies Market Size by Country
6.4.1 North America IGY Polyclonal Antibodies Market Size by Country (2016-2021)
6.4.2 North America IGY Polyclonal Antibodies Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe IGY Polyclonal Antibodies Market Size (2016-2027)
7.2 Europe IGY Polyclonal Antibodies Market Size by Type
7.2.1 Europe IGY Polyclonal Antibodies Market Size by Type (2016-2021)
7.2.2 Europe IGY Polyclonal Antibodies Market Size by Type (2022-2027)
7.2.3 Europe IGY Polyclonal Antibodies Market Size by Type (2016-2027)
7.3 Europe IGY Polyclonal Antibodies Market Size by Application
7.3.1 Europe IGY Polyclonal Antibodies Market Size by Application (2016-2021)
7.3.2 Europe IGY Polyclonal Antibodies Market Size by Application (2022-2027)
7.3.3 Europe IGY Polyclonal Antibodies Market Size by Application (2016-2027)
7.4 Europe IGY Polyclonal Antibodies Market Size by Country
7.4.1 Europe IGY Polyclonal Antibodies Market Size by Country (2016-2021)
7.4.2 Europe IGY Polyclonal Antibodies Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific IGY Polyclonal Antibodies Market Size (2016-2027)
8.2 Asia-Pacific IGY Polyclonal Antibodies Market Size by Type
8.2.1 Asia-Pacific IGY Polyclonal Antibodies Market Size by Type (2016-2021)
8.2.2 Asia-Pacific IGY Polyclonal Antibodies Market Size by Type (2022-2027)
8.2.3 Asia-Pacific IGY Polyclonal Antibodies Market Size by Type (2016-2027)
8.3 Asia-Pacific IGY Polyclonal Antibodies Market Size by Application
8.3.1 Asia-Pacific IGY Polyclonal Antibodies Market Size by Application (2016-2021)
8.3.2 Asia-Pacific IGY Polyclonal Antibodies Market Size by Application (2022-2027)
8.3.3 Asia-Pacific IGY Polyclonal Antibodies Market Size by Application (2016-2027)
8.4 Asia-Pacific IGY Polyclonal Antibodies Market Size by Region
8.4.1 Asia-Pacific IGY Polyclonal Antibodies Market Size by Region (2016-2021)
8.4.2 Asia-Pacific IGY Polyclonal Antibodies Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America IGY Polyclonal Antibodies Market Size (2016-2027)
9.2 Latin America IGY Polyclonal Antibodies Market Size by Type
9.2.1 Latin America IGY Polyclonal Antibodies Market Size by Type (2016-2021)
9.2.2 Latin America IGY Polyclonal Antibodies Market Size by Type (2022-2027)
9.2.3 Latin America IGY Polyclonal Antibodies Market Size by Type (2016-2027)
9.3 Latin America IGY Polyclonal Antibodies Market Size by Application
9.3.1 Latin America IGY Polyclonal Antibodies Market Size by Application (2016-2021)
9.3.2 Latin America IGY Polyclonal Antibodies Market Size by Application (2022-2027)
9.3.3 Latin America IGY Polyclonal Antibodies Market Size by Application (2016-2027)
9.4 Latin America IGY Polyclonal Antibodies Market Size by Country
9.4.1 Latin America IGY Polyclonal Antibodies Market Size by Country (2016-2021)
9.4.2 Latin America IGY Polyclonal Antibodies Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa IGY Polyclonal Antibodies Market Size (2016-2027)
10.2 Middle East & Africa IGY Polyclonal Antibodies Market Size by Type
10.2.1 Middle East & Africa IGY Polyclonal Antibodies Market Size by Type (2016-2021)
10.2.2 Middle East & Africa IGY Polyclonal Antibodies Market Size by Type (2022-2027)
10.2.3 Middle East & Africa IGY Polyclonal Antibodies Market Size by Type (2016-2027)
10.3 Middle East & Africa IGY Polyclonal Antibodies Market Size by Application
10.3.1 Middle East & Africa IGY Polyclonal Antibodies Market Size by Application (2016-2021)
10.3.2 Middle East & Africa IGY Polyclonal Antibodies Market Size by Application (2022-2027)
10.3.3 Middle East & Africa IGY Polyclonal Antibodies Market Size by Application (2016-2027)
10.4 Middle East & Africa IGY Polyclonal Antibodies Market Size by Country
10.4.1 Middle East & Africa IGY Polyclonal Antibodies Market Size by Country (2016-2021)
10.4.2 Middle East & Africa IGY Polyclonal Antibodies Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Merck
11.1.1 Merck Company Details
11.1.2 Merck Business Overview
11.1.3 Merck IGY Polyclonal Antibodies Introduction
11.1.4 Merck Revenue in IGY Polyclonal Antibodies Business (2016-2021)
11.1.5 Merck Recent Development
11.2 IGY Life Sciences
11.2.1 IGY Life Sciences Company Details
11.2.2 IGY Life Sciences Business Overview
11.2.3 IGY Life Sciences IGY Polyclonal Antibodies Introduction
11.2.4 IGY Life Sciences Revenue in IGY Polyclonal Antibodies Business (2016-2021)
11.2.5 IGY Life Sciences Recent Development
11.3 Abcam
11.3.1 Abcam Company Details
11.3.2 Abcam Business Overview
11.3.3 Abcam IGY Polyclonal Antibodies Introduction
11.3.4 Abcam Revenue in IGY Polyclonal Antibodies Business (2016-2021)
11.3.5 Abcam Recent Development
11.4 Genway Biotech
11.4.1 Genway Biotech Company Details
11.4.2 Genway Biotech Business Overview
11.4.3 Genway Biotech IGY Polyclonal Antibodies Introduction
11.4.4 Genway Biotech Revenue in IGY Polyclonal Antibodies Business (2016-2021)
11.4.5 Genway Biotech Recent Development
11.5 Good Biotech
11.5.1 Good Biotech Company Details
11.5.2 Good Biotech Business Overview
11.5.3 Good Biotech IGY Polyclonal Antibodies Introduction
11.5.4 Good Biotech Revenue in IGY Polyclonal Antibodies Business (2016-2021)
11.5.5 Good Biotech Recent Development
11.6 Gallus Immunotech
11.6.1 Gallus Immunotech Company Details
11.6.2 Gallus Immunotech Business Overview
11.6.3 Gallus Immunotech IGY Polyclonal Antibodies Introduction
11.6.4 Gallus Immunotech Revenue in IGY Polyclonal Antibodies Business (2016-2021)
11.6.5 Gallus Immunotech Recent Development
11.7 Creative Diagnostics
11.7.1 Creative Diagnostics Company Details
11.7.2 Creative Diagnostics Business Overview
11.7.3 Creative Diagnostics IGY Polyclonal Antibodies Introduction
11.7.4 Creative Diagnostics Revenue in IGY Polyclonal Antibodies Business (2016-2021)
11.7.5 Creative Diagnostics Recent Development
11.8 Agrisera
11.8.1 Agrisera Company Details
11.8.2 Agrisera Business Overview
11.8.3 Agrisera IGY Polyclonal Antibodies Introduction
11.8.4 Agrisera Revenue in IGY Polyclonal Antibodies Business (2016-2021)
11.8.5 Agrisera Recent Development
11.9 Innovagen AB
11.9.1 Innovagen AB Company Details
11.9.2 Innovagen AB Business Overview
11.9.3 Innovagen AB IGY Polyclonal Antibodies Introduction
11.9.4 Innovagen AB Revenue in IGY Polyclonal Antibodies Business (2016-2021)
11.9.5 Innovagen AB Recent Development
11.10 Capra Science
11.10.1 Capra Science Company Details
11.10.2 Capra Science Business Overview
11.10.3 Capra Science IGY Polyclonal Antibodies Introduction
11.10.4 Capra Science Revenue in IGY Polyclonal Antibodies Business (2016-2021)
11.10.5 Capra Science Recent Development
11.11 YO Proteins
11.11.1 YO Proteins Company Details
11.11.2 YO Proteins Business Overview
11.11.3 YO Proteins IGY Polyclonal Antibodies Introduction
11.11.4 YO Proteins Revenue in IGY Polyclonal Antibodies Business (2016-2021)
11.11.5 YO Proteins Recent Development
11.12 GeneTex
11.12.1 GeneTex Company Details
11.12.2 GeneTex Business Overview
11.12.3 GeneTex IGY Polyclonal Antibodies Introduction
11.12.4 GeneTex Revenue in IGY Polyclonal Antibodies Business (2016-2021)
11.12.5 GeneTex Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global IGY Polyclonal Antibodies Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Primary Antibody
Table 3. Key Players of Secondary Antibody
Table 4. Global IGY Polyclonal Antibodies Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global IGY Polyclonal Antibodies Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global IGY Polyclonal Antibodies Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global IGY Polyclonal Antibodies Market Share by Regions (2016-2021)
Table 8. Global IGY Polyclonal Antibodies Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global IGY Polyclonal Antibodies Market Share by Regions (2022-2027)
Table 10. IGY Polyclonal Antibodies Market Trends
Table 11. IGY Polyclonal Antibodies Market Drivers
Table 12. IGY Polyclonal Antibodies Market Challenges
Table 13. IGY Polyclonal Antibodies Market Restraints
Table 14. Global IGY Polyclonal Antibodies Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global IGY Polyclonal Antibodies Market Share by Players (2016-2021)
Table 16. Global Top IGY Polyclonal Antibodies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in IGY Polyclonal Antibodies as of 2020)
Table 17. Ranking of Global Top IGY Polyclonal Antibodies Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by IGY Polyclonal Antibodies Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players IGY Polyclonal Antibodies Product Solution and Service
Table 21. Date of Enter into IGY Polyclonal Antibodies Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global IGY Polyclonal Antibodies Market Size by Type (2016-2021) (US$ Million)
Table 24. Global IGY Polyclonal Antibodies Revenue Market Share by Type (2016-2021)
Table 25. Global IGY Polyclonal Antibodies Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global IGY Polyclonal Antibodies Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global IGY Polyclonal Antibodies Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global IGY Polyclonal Antibodies Revenue Market Share by Application (2016-2021)
Table 29. Global IGY Polyclonal Antibodies Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global IGY Polyclonal Antibodies Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America IGY Polyclonal Antibodies Market Size by Type (2016-2021) (US$ Million)
Table 32. North America IGY Polyclonal Antibodies Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America IGY Polyclonal Antibodies Market Size by Application (2016-2021) (US$ Million)
Table 34. North America IGY Polyclonal Antibodies Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America IGY Polyclonal Antibodies Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America IGY Polyclonal Antibodies Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe IGY Polyclonal Antibodies Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe IGY Polyclonal Antibodies Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe IGY Polyclonal Antibodies Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe IGY Polyclonal Antibodies Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe IGY Polyclonal Antibodies Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe IGY Polyclonal Antibodies Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific IGY Polyclonal Antibodies Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific IGY Polyclonal Antibodies Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific IGY Polyclonal Antibodies Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific IGY Polyclonal Antibodies Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific IGY Polyclonal Antibodies Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific IGY Polyclonal Antibodies Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America IGY Polyclonal Antibodies Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America IGY Polyclonal Antibodies Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America IGY Polyclonal Antibodies Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America IGY Polyclonal Antibodies Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America IGY Polyclonal Antibodies Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America IGY Polyclonal Antibodies Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa IGY Polyclonal Antibodies Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa IGY Polyclonal Antibodies Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa IGY Polyclonal Antibodies Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa IGY Polyclonal Antibodies Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa IGY Polyclonal Antibodies Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa IGY Polyclonal Antibodies Market Size by Country (2022-2027) & (US$ Million)
Table 61. Merck Company Details
Table 62. Merck Business Overview
Table 63. Merck IGY Polyclonal Antibodies Product
Table 64. Merck Revenue in IGY Polyclonal Antibodies Business (2016-2021) & (US$ Million)
Table 65. Merck Recent Development
Table 66. IGY Life Sciences Company Details
Table 67. IGY Life Sciences Business Overview
Table 68. IGY Life Sciences IGY Polyclonal Antibodies Product
Table 69. IGY Life Sciences Revenue in IGY Polyclonal Antibodies Business (2016-2021) & (US$ Million)
Table 70. IGY Life Sciences Recent Development
Table 71. Abcam Company Details
Table 72. Abcam Business Overview
Table 73. Abcam IGY Polyclonal Antibodies Product
Table 74. Abcam Revenue in IGY Polyclonal Antibodies Business (2016-2021) & (US$ Million)
Table 75. Abcam Recent Development
Table 76. Genway Biotech Company Details
Table 77. Genway Biotech Business Overview
Table 78. Genway Biotech IGY Polyclonal Antibodies Product
Table 79. Genway Biotech Revenue in IGY Polyclonal Antibodies Business (2016-2021) & (US$ Million)
Table 80. Genway Biotech Recent Development
Table 81. Good Biotech Company Details
Table 82. Good Biotech Business Overview
Table 83. Good Biotech IGY Polyclonal Antibodies Product
Table 84. Good Biotech Revenue in IGY Polyclonal Antibodies Business (2016-2021) & (US$ Million)
Table 85. Good Biotech Recent Development
Table 86. Gallus Immunotech Company Details
Table 87. Gallus Immunotech Business Overview
Table 88. Gallus Immunotech IGY Polyclonal Antibodies Product
Table 89. Gallus Immunotech Revenue in IGY Polyclonal Antibodies Business (2016-2021) & (US$ Million)
Table 90. Gallus Immunotech Recent Development
Table 91. Creative Diagnostics Company Details
Table 92. Creative Diagnostics Business Overview
Table 93. Creative Diagnostics IGY Polyclonal Antibodies Product
Table 94. Creative Diagnostics Revenue in IGY Polyclonal Antibodies Business (2016-2021) & (US$ Million)
Table 95. Creative Diagnostics Recent Development
Table 96. Agrisera Company Details
Table 97. Agrisera Business Overview
Table 98. Agrisera Revenue in IGY Polyclonal Antibodies Business (2016-2021) & (US$ Million)
Table 99. Agrisera Recent Development
Table 100. Innovagen AB Company Details
Table 101. Innovagen AB Business Overview
Table 102. Innovagen AB IGY Polyclonal Antibodies Product
Table 103. Innovagen AB Revenue in IGY Polyclonal Antibodies Business (2016-2021) & (US$ Million)
Table 104. Innovagen AB Recent Development
Table 105. Capra Science Company Details
Table 106. Capra Science Business Overview
Table 107. Capra Science IGY Polyclonal Antibodies Product
Table 108. Capra Science Revenue in IGY Polyclonal Antibodies Business (2016-2021) & (US$ Million)
Table 109. Capra Science Recent Development
Table 110. YO Proteins Company Details
Table 111. YO Proteins Business Overview
Table 112. YO Proteins IGY Polyclonal Antibodies Product
Table 113. YO Proteins Revenue in IGY Polyclonal Antibodies Business (2016-2021) & (US$ Million)
Table 114. YO Proteins Recent Development
Table 115. GeneTex Company Details
Table 116. GeneTex Business Overview
Table 117. GeneTex IGY Polyclonal Antibodies Product
Table 118. GeneTex Revenue in IGY Polyclonal Antibodies Business (2016-2021) & (US$ Million)
Table 119. GeneTex Recent Development
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
List of Figures
Figure 1. Global IGY Polyclonal Antibodies Market Share by Type: 2020 VS 2027
Figure 2. Primary Antibody Features
Figure 3. Secondary Antibody Features
Figure 4. Global IGY Polyclonal Antibodies Market Share by Application: 2020 VS 2027
Figure 5. Academic Research Case Studies
Figure 6. Commercial Case Studies
Figure 7. IGY Polyclonal Antibodies Report Years Considered
Figure 8. Global IGY Polyclonal Antibodies Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 9. Global IGY Polyclonal Antibodies Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global IGY Polyclonal Antibodies Market Share by Regions: 2020 VS 2027
Figure 11. Global IGY Polyclonal Antibodies Market Share by Regions (2022-2027)
Figure 12. Global IGY Polyclonal Antibodies Market Share by Players in 2020
Figure 13. Global Top IGY Polyclonal Antibodies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in IGY Polyclonal Antibodies as of 2020
Figure 14. The Top 10 and 5 Players Market Share by IGY Polyclonal Antibodies Revenue in 2020
Figure 15. Global IGY Polyclonal Antibodies Revenue Market Share by Type (2016-2021)
Figure 16. Global IGY Polyclonal Antibodies Revenue Market Share by Type (2022-2027)
Figure 17. North America IGY Polyclonal Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 18. North America IGY Polyclonal Antibodies Market Share by Type (2016-2027)
Figure 19. North America IGY Polyclonal Antibodies Market Share by Application (2016-2027)
Figure 20. North America IGY Polyclonal Antibodies Market Share by Country (2016-2027)
Figure 21. United States IGY Polyclonal Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. Canada IGY Polyclonal Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Europe IGY Polyclonal Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe IGY Polyclonal Antibodies Market Share by Type (2016-2027)
Figure 25. Europe IGY Polyclonal Antibodies Market Share by Application (2016-2027)
Figure 26. Europe IGY Polyclonal Antibodies Market Share by Country (2016-2027)
Figure 27. Germany IGY Polyclonal Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. France IGY Polyclonal Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. U.K. IGY Polyclonal Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Italy IGY Polyclonal Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Russia IGY Polyclonal Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Nordic IGY Polyclonal Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Asia-Pacific IGY Polyclonal Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific IGY Polyclonal Antibodies Market Share by Type (2016-2027)
Figure 35. Asia-Pacific IGY Polyclonal Antibodies Market Share by Application (2016-2027)
Figure 36. Asia-Pacific IGY Polyclonal Antibodies Market Share by Region (2016-2027)
Figure 37. China IGY Polyclonal Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Japan IGY Polyclonal Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. South Korea IGY Polyclonal Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Southeast Asia IGY Polyclonal Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. India IGY Polyclonal Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Australia IGY Polyclonal Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Latin America IGY Polyclonal Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America IGY Polyclonal Antibodies Market Share by Type (2016-2027)
Figure 45. Latin America IGY Polyclonal Antibodies Market Share by Application (2016-2027)
Figure 46. Latin America IGY Polyclonal Antibodies Market Share by Country (2016-2027)
Figure 47. Mexico IGY Polyclonal Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Brazil IGY Polyclonal Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Middle East & Africa IGY Polyclonal Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa IGY Polyclonal Antibodies Market Share by Type (2016-2027)
Figure 51. Middle East & Africa IGY Polyclonal Antibodies Market Share by Application (2016-2027)
Figure 52. Middle East & Africa IGY Polyclonal Antibodies Market Share by Country (2016-2027)
Figure 53. Turkey IGY Polyclonal Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Saudi Arabia IGY Polyclonal Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. UAE IGY Polyclonal Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Merck Revenue Growth Rate in IGY Polyclonal Antibodies Business (2016-2021)
Figure 57. IGY Life Sciences Revenue Growth Rate in IGY Polyclonal Antibodies Business (2016-2021)
Figure 58. Abcam Revenue Growth Rate in IGY Polyclonal Antibodies Business (2016-2021)
Figure 59. Genway Biotech Revenue Growth Rate in IGY Polyclonal Antibodies Business (2016-2021)
Figure 60. Good Biotech Revenue Growth Rate in IGY Polyclonal Antibodies Business (2016-2021)
Figure 61. Gallus Immunotech Revenue Growth Rate in IGY Polyclonal Antibodies Business (2016-2021)
Figure 62. Creative Diagnostics Revenue Growth Rate in IGY Polyclonal Antibodies Business (2016-2021)
Figure 63. Agrisera Revenue Growth Rate in IGY Polyclonal Antibodies Business (2016-2021)
Figure 64. Innovagen AB Revenue Growth Rate in IGY Polyclonal Antibodies Business (2016-2021)
Figure 65. Capra Science Revenue Growth Rate in IGY Polyclonal Antibodies Business (2016-2021)
Figure 66. YO Proteins Revenue Growth Rate in IGY Polyclonal Antibodies Business (2016-2021)
Figure 67. GeneTex Revenue Growth Rate in IGY Polyclonal Antibodies Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
世界の診断用特殊抗体市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Diagnostic Specialty Antibody Market The global Diagnostic Specialty Antibody market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integ…- 世界のSTAB2抗体（スタビリン-2前駆体）市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global STAB2 Antibody (Stabilin-2 Precursor) Market The global STAB2 Antibody (Stabilin-2 Precursor) market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and…
- 世界の診断用特殊抗体市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Diagnostic Specialty Antibodies Market The global Diagnostic Specialty Antibodies market size is projected to reach US$ 24780 million by 2026, from US$ 20090 million in 2019, at a CAGR of 3.0% during 2021-2026. With industry-standard accuracy in analysis and high…
- 世界の診断用特殊抗体市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Diagnostic Specialty Antibodies Market The global Diagnostic Specialty Antibodies market size is projected to reach US$ 24780 million by 2026, from US$ 20090 million in 2019, at a CAGR of 3.0% during 2021-2026. With industry-standard accuracy in analysis and high…
- 世界のEXTL1抗体市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global EXTL1 Antibody Market The global EXTL1 Antibody market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the report makes a brill…